Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection - Test2 - elhamkhani - TriplyDB

Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection

Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection

http://www.wikidata.org/entity/Q24701792

about

Infectious Chikungunya Virus in the Saliva of Mice, Monkeys and Humans Mutations conferring a noncytotoxic phenotype on chikungunya virus replicons compromise enzymatic properties of nonstructural protein 2 Expanding Regulatory T Cells Alleviates Chikungunya Virus-Induced Pathology in Mice Nonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model)Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera Mechanism and role of MCP-1 upregulation upon chikungunya virus infection in human peripheral blood mononuclear cells Prolonged shedding of Chikungunya virus in semen and urine: A new perspective for diagnosis and implications for transmission Persistent RNA virus infections: do PAMPS drive chronic disease?RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies.Development of Vaccines for Chikungunya Fever.Animal Models of Chikungunya Virus Infection and Disease.Molecular Characterisation of Clinical Isolates of Chikungunya Virus: A Study from Tertiary Care Hospitals in Southern India.Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques.Phenotypic and functional analyses of NK and NKT-like populations during the early stages of chikungunya infection The neutralizing role of IgM during early Chikungunya virus infection Detection of Persistent Chikungunya Virus RNA but not Infectious Virus in Experimental Vertical Transmission in Aedes aegypti from Malaysia.Chronic chikungunya virus musculoskeletal disease: what are the underlying mechanisms?Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence.Chikungunya virus transmission between Aedes albopictus and laboratory mice.Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus.MUTATIONS IN THE E2 GLYCOPROTEIN AND THE 3' UNTRANSLATED REGION ENHANCE CHIKUNGUNYA VIRUS VIRULENCE IN MICE.Imported cases of Chikungunya in Barcelona in relation to the current American outbreak.Immune-Mediated Protection and Pathogenesis of Chikungunya Virus.Chikungunya Virus Vaccines: Viral Vector-Based Approaches.Transcriptomic Analyses Reveal Differential Gene Expression of Immune and Cell Death Pathways in the Brains of Mice Infected with West Nile Virus and Chikungunya Virus.Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology.Chikungunya Virus Infection: Why Should U.S. Geriatricians Be Aware of It?Differential inhibitory and activating NK cell receptor levels and NK/NKT-like cell functionality in chronic and recovered stages of chikungunya.Lower temperatures reduce type I interferon activity and promote alphaviral arthritis.A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses.Mayaro virus: a neglected arbovirus of the Americas The new European invader Aedes (Finlaya) koreicus: a potential vector of chikungunya virus Chikungunya virus impairs draining lymph node function by inhibiting HEV-mediated lymphocyte recruitment Persistent Replication of a Chikungunya Virus Replicon in Human Cells Is Associated with Presence of Stable Cytoplasmic Granules Containing Nonstructural Protein 3

P2860

Q24288650-11CEEEBE-DA6E-4DB5-A613-B747957E4360 Q24701750-0DC77B24-2F58-4F41-839A-E31563B52D7B Q24701758-4826DF22-8CAA-4AC1-BA75-DA8C3C701203 Q26782722-630EDD67-F1F4-48DA-87AD-22B9D2D82843 Q27468808-2130CD5D-08A9-4FE0-B35E-ADE4D0F06269 Q27468832-FDBB37BF-8ECE-44BC-84D9-00E404A9BBEF Q27926247-D3A75D35-A50E-4B78-82AE-E923EA8135CB Q28804036-E8EE18FD-F649-4F35-B8C6-EAFCA3BC5824 Q28804081-861AEDBA-638C-4546-B3C3-8CD526ADC97F Q30235512-CCBC2F43-1FD0-4831-BBC3-6EBDE947804F Q30240191-CEFDAB70-21CC-4843-A3C9-C98669CA2730 Q30240216-9C1A1610-34DF-43E9-BE1B-F33BE92FF0D1 Q30387546-BCA0E5A3-E66E-41CA-80C2-56CFF924E86D Q33853893-2D6AD28A-E27D-4FC0-9606-A3E86B79739E Q36012210-08E45021-F060-44DA-84E0-A367CAE444AF Q36275851-B26B935C-EF39-4478-A9A3-89286D2EA354 Q36455781-40EC4620-B741-4109-80B0-42784370C930 Q36828876-602CE57F-0534-4B50-A83B-6F495016C504 Q37214518-9979C864-4EE0-47CC-AE8A-B4B1A6630E6C Q37349608-0A5223EB-E47E-49F1-B9E1-2D48DB2732A5 Q37711813-B5CD43D4-314F-4EC6-BD4F-AE6E5DCCAFE3 Q38659305-77EDF2C2-75BB-49EA-9185-844D1C132D16 Q38912574-449E3932-D83A-4524-B260-F2EE525F815E Q39013750-367176E4-CCDD-44E5-944A-9AD8A3B00C1C Q39128566-F0A48235-81BB-418F-A430-630747EB1024 Q40061942-465742A8-C4CA-411B-B6B4-8C6739735501 Q40117821-5FC99E95-CFC6-4E37-99CC-EF0CB54DE6AC Q41931672-035B58A6-E752-48F7-87E4-203761A22DD8 Q44843505-D981BDD8-885F-487C-B6DC-86877904EBF9 Q47242810-61F606E8-6E4C-4B95-9B9F-1AE296070ACD Q51336011-0DE2A419-19A9-4A4C-85C2-C6A9DAECF7DB Q56378882-2BF4C4ED-42BB-450A-95FA-7E298178C211 Q56798276-6A7F4FF8-451F-4E59-B925-71C8F45B802E Q57023103-67BBA7BC-E7E1-4FD6-A2EE-A4E4A12B5D19 Q57905120-AA65D20F-BD05-47DD-B097-204A33C01477

P2860

Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection

http://www.wikidata.org/entity/Q24701792

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Multiple immune factors are in ...... ic chikungunya virus infection

@ast

Multiple immune factors are in ...... ic chikungunya virus infection

@en

Multiple immune factors are in ...... ic chikungunya virus infection

@nl

type

label

Multiple immune factors are in ...... ic chikungunya virus infection

@ast

Multiple immune factors are in ...... ic chikungunya virus infection

@en

Multiple immune factors are in ...... ic chikungunya virus infection

@nl

prefLabel

Multiple immune factors are in ...... ic chikungunya virus infection

@ast

Multiple immune factors are in ...... ic chikungunya virus infection

@en

Multiple immune factors are in ...... ic chikungunya virus infection

@nl

P1433

Q24701792-FCFDED84-23E5-431F-BC82-B467814B38E2

P1476

Q24701792-28CCDFAC-7530-4413-AF05-35D69BD46E83

P2093

Q24701792-0234290C-EC8B-41AD-BA86-E2F888682F43

Q24701792-10A651F2-65C8-4B3F-AFDD-1752A79B0E01

Q24701792-2554DF2B-FB2D-4F99-B682-0A2A946D7A02

Q24701792-27258810-19F7-46F6-A50F-BA76BA7AD9C3

Q24701792-2B799040-7082-49EF-A7BF-B560299BA9C9

Q24701792-87ED78C6-869E-42D9-B2A9-B99EDC715EF2

Q24701792-ABBD9A25-1652-485D-AFE6-F6D60573DC59

Q24701792-DE363053-9070-41BB-8A39-1AC35096999D

Q24701792-E269C3ED-2AA7-49FC-A5D6-E5373AF50CBF

Q24701792-E31C2A17-ACF4-4919-9B56-57808FE36BE0

P275

Q24701792-03A3072D-CA4B-4FD9-926B-12B473EE20C1

P2860

Q24701792-013CF1F1-8094-45E1-9893-699951BE7DD3

Q24701792-06725A30-BE5A-41D4-93C6-1F9B8A03F616

Q24701792-0D3A7693-A308-4C64-917F-AB99493C9F75

Q24701792-10368F40-9BC4-4029-99C4-7AE7912C3581

Q24701792-10D417BE-113B-4F5F-B7C7-23FA0C620509

Q24701792-13EAD01E-21E1-4B59-8BC6-07FCAFC42BEF

Q24701792-1551218A-8FFA-464C-8E90-DDED2015E468

Q24701792-1E06BDCC-B49B-4AE3-9999-5760F566867D

Q24701792-1FA4546C-59DF-48A2-A649-9A8DE5F360C3

Q24701792-210655FC-9273-421A-AE1E-C6455707AE15

P304

Q24701792-C145D256-2CB5-4C61-8018-C1E37B391278

P31

Q24701792-2AEC29D0-CC8B-4571-BDE8-B9D215587740

P3181

Q24701792-B1FD1FE4-CBE1-4F88-8EB7-5C0E27B6FCC2

P356

Q24701792-8251DDEF-B611-4E9A-9702-97F68676BF61

P407

Q24701792-198FBF22-C363-49FF-9F89-E7DC3DDC2DC3

P433

Q24701792-FDB6950B-5254-4213-8AC1-CAB9BBCA3B50

P478

Q24701792-0C21F64A-3595-4C2D-B90E-96261C2CF492

P50

Q24701792-2B56C248-C821-4D55-B741-D3626E048428

Q24701792-3E9B3205-110A-45B6-8A9C-FDB8C9FCED7C

Q24701792-4811430F-FAF2-4EED-8BC7-75FE3BD486AB

Q24701792-9307AB1D-2347-469C-A25F-F27F5EA3854E

Q24701792-A0B53B38-2BDD-4CE6-95B8-EB05B5A75DBD

P5008

Q24701792-9DEF371C-36D3-45C2-9A06-1723F60FBB15

P577

Q24701792-DBA3C029-3CF6-4D4D-93FC-525C9FA5C645

P5875

Q24701792-AAFEF646-4D27-4E06-B6D3-C929467EC781

P698

Q24701792-DD1EB58E-6727-4300-99C0-4887B1992AA3

P921

Q24701792-CB72154F-4643-446A-AF33-7BB6CC932707

P932

Q24701792-6C3F2C03-16B6-4089-9DAC-8E288BDCF806

P3181

P356

JOURNAL.PNTD.0003354

P1433

PLOS Neglected Tropical Diseases

P1476

Multiple immune factors are in ...... ic chikungunya virus infection

@en

P2093

David Warrilow

http://www.w3.org/2001/XMLSchema#string

Jane A C Wilson

http://www.w3.org/2001/XMLSchema#string

José A Lopez

http://www.w3.org/2001/XMLSchema#string

Joy Gardner

http://www.w3.org/2001/XMLSchema#string

Marie-Anne Colle

http://www.w3.org/2001/XMLSchema#string

Penny A Rudd

http://www.w3.org/2001/XMLSchema#string

Richard Allcock

http://www.w3.org/2001/XMLSchema#string

Thuy T Le

http://www.w3.org/2001/XMLSchema#string

Wayne A Schroder

http://www.w3.org/2001/XMLSchema#string

Yee Suan Poo

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease

Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages

Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling

Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock

RNA virus error catastrophe: direct molecular test by using ribavirin

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

Arbovirus high fidelity variant loses fitness in mosquitoes and mice

Type I IFN controls chikungunya virus via its action on nonhematopoietic cells

CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritis

Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus

P304

e3354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2906509

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PNTD.0003354

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Alexander A. Khromykh

Thibaut Larcher

Helle Bielefeldt-Ohmann

Andreas Suhrbier

P5008

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269174008

http://www.w3.org/2001/XMLSchema#string

P698

25474568

http://www.w3.org/2001/XMLSchema#string

P921

Chikungunya virus

P932

4256279

http://www.w3.org/2001/XMLSchema#string